Pharmagene Financing To Grow Preclinical Human Tissue Research Service
Executive Summary
The U.K. biotech company Pharmagene will use a private placement of $13.8 mil. (L8.6 mil.) to expand the company's Phase Zero target validation technologies and database products.
You may also be interested in...
Pharmagene PLC To Set Up U.S. Base After IPO Raises $56 Mil.
U.K. drug discovery and development company Pharmagene plans to launch its informatics business in the U.S. following an initial public offering on the London Stock Exchange.
Pharmagene PLC To Set Up U.S. Base After IPO Raises $56 Mil.
U.K. drug discovery and development company Pharmagene plans to launch its informatics business in the U.S. following an initial public offering on the London Stock Exchange.
Celltech Chiroscience Strikes Chirocaine Deal With Abbott/Purdue
The local anesthetic Chirocaine (levobupivacaine) will be the first commercialized drug from the merged U.K. biopharmaceutical entity Celltech Chiroscience.